Chemotherapy Combined with Immunotherapy and Targeted Therapy in Cholangiocarcinoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Chemotherapy Combined with Immunotherapy and Targeted Therapy in Cholangiocarcinoma — Stella

Recruiting

Back to Cholangiocarcinoma trials

Trial locations(1 site)

China

2nd Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang

Key details

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment target

~300 participants

Started

September 2024

Primary completion

March 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov